Table 1.
Comparison of demographics and clinical assessments: Preeclampsia cases vs Controls.
Mean (SD) | p-value | ||
---|---|---|---|
Preeclampsia | Controls | ||
Number | 35 | 63 | — |
Age | 32.3 (5.5) | 32.6 (5.8) | 0.83+ |
Parity | |||
• Nulliparous | 18 | 37 | 0.43* |
• Multiparous | 17 | 26 | |
Race | |||
• White (n) | 15 | 39 | 0.13^ |
• Black (n) | 16 | 19 | |
• Asian (n) | 4 | 3 | |
• Mixed (n) | 0 | 2 | |
BMI (11+0–13+6 wks) | 27.1 (6.4) | 25.6 (4.2) | 0.14+ |
BMI (32+0–33+6 wks) | 29.0 (7.1) | 29.4 (5.8) | 0.79+ |
MAP mom (11+0–13+6 wks) | 1.013 (0.071) | 1.032 (0.090) | 0.28+ |
MAP mom (32+0–33+6 wks) | 1.015 (0.080) | 1.027 (0.093) | 0.54+ |
Previous PE, N (%) | |||
• Multipara-PE history | 4 (12%) | 5 (9%) | 0.21# |
• Multipara-no PE history | 13 (37%) | 21 (33%) | |
• Nullipara | 18 (51%) | 37 (58%) | |
FH PE-Mother, N (%) | 1 | 0 | — |
BMI: Body mass index, MAP: Mean arterial pressure, PGFL: Placenta growth factor, FH PE-Mother: Family history of Preeclampsia - Mother. +t-test.
*Chi square test.
^Kruskal Wallis.
#Fisher’s Exact test.